{
  "id": 1849179,
  "title": "Meiragtx CEO Forbes sells $859,320 in company stock",
  "url": "https://urgent.news/2026/08/19/meiragtx-ceo-forbes-sells-859-320-in-company-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-19T02:31:03.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/meiragtx-ceo-forbes-sells-859320-in-company-stock-93CH-4866377"
  },
  "original_language": "en",
  "account": "Alexandria Forbes, CEO of MeiraGTx Holdings plc, sold 62,000 shares of the company on August 18, 2026, for a total of $859,320. The shares were sold at an average price of $13.86, between $13.59 and $14.00 per share. MeiraGTx's stock is currently trading at $13.89, close to its 52-week high of $15.35, following an 83% increase over the past year. These sales were made under a pre-approved trading plan adopted by Forbes in November 2025. After these transactions, Forbes still owns 1,325,695 shares of MeiraGTx. Analysts report the stock appears fairly valued, and the company has a strong financial health score. There are 13 further tips available on MeiraGTx's InvestingPro platform, covering aspects like profitability and valuation. MeiraGTx recently secured a $400 million investment from Oberland Capital Management LLC, including non-dilutive capital and equity. H.C. Wainwright maintains a Buy rating for MeiraGTx, with a price target of $20.00. At the company's annual general meeting, shareholders elected three Class II directors for service until 2029, alongside approving the company's auditor.",
  "summary": null,
  "key_points": [
    "CEO Alexandria Forbes sold 62,000 MeiraGTx shares for $859,320 on August 18, 2026.",
    "Shares sold at average price $13.86 between $13.59-$14.00 per share.",
    "Forbes retains 1,325,695 MeiraGTx shares after transactions."
  ],
  "editors_take": "The CEO's sale of company stock under a pre-approved trading plan does not seem to have impacted analyst confidence, with H.C. Wainwright maintaining a Buy rating and the stock appearing fairly valued.",
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Pacific Biosciences CEO Mark van Oene sells $30,409 in stock",
        "url": "https://urgent.news/2026/08/19/pacific-biosciences-ceo-mark-van-oene-sells-30-409-in-stock",
        "published": "2026-08-19T02:15:56.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}